Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|December 13, 2017
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated MyelomaMaría-Victoria Mateos, Meletios A Dimopoulos, Michele Cavo, et al.
Blood|September 12, 2022
Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agentsAdam D Cohen, María-Victoria Mateos, Yael C Cohen, et al.
Lancet (London, England)|December 15, 2019
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trialMaria-Victoria Mateos, Michele Cavo, Joan Blade, et al.
Blood Cancer Journal|September 5, 2020
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 studyMeletios A Dimopoulos, Sagar Lonial, Darrell White, et al.
Blood Advances|July 26, 2024
Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in multiple myelomaMaria Luisa Palacios-Berraquero, Paula Rodriguez-Marquez, Maria Erendira Calleja-Cervantes, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 20, 2023
AG5 is a potent non-steroidal anti-inflammatory and immune regulator that preserves innate immunityPablo Botella-Asunción, Eva M Rivero-Buceta, Carla Vidaurre-Agut, et al.
Blood|July 21, 2021
Prognostic value of minimal residual disease negativity in myeloma: combined analysis of POLLUX, CASTOR, ALCYONE, and MAIAMichele Cavo, Jesus San-Miguel, Saad Z Usmani, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|December 13, 2003
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma FoundationBrian G M Durie, Robert A Kyle, Andrew Belch, et al.
Haematologica|March 1, 2013
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trialsSara Bringhen, Maria Victoria Mateos, Sonja Zweegman, et al.
Leukemia|August 21, 2020
Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma NetworkHeinz Ludwig, Mario Boccadoro, Philippe Moreau, et al.
Pageof 13